Physician profile
Eric Alan Crawley
NPI 1497745988
$17,197.68
in general payments reported to CMS, 2019-2025
17 companies · $6,162 in 2025
The $6,162 reported for 2025 was more than what 90% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,114 · 2020: $181 · 2021: $411 · 2022: $457 · 2023: $4,610 · 2024: $3,264 · 2025: $6,162.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $7,045 · Education: $3,000 · Food and Beverage: $2,190 · Consulting Fee: $1,800.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $7,045.00 |
| Education | $3,000.00 |
| Food and Beverage | $2,190.47 |
| Consulting Fee | $1,800.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $7,502.66 | 2021-2025 | Illumisite |
| Intuitive Surgical, INC. | $4,084.15 | 2020-2025 | |
| Pulmonx Corporation | $1,911.39 | 2023-2024 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Zephyr Endobronchial Valve |
| Astrazeneca Pharmaceuticals LP | $1,556.00 | 2019 | |
| Glaxosmithkline, LLC. | $485.17 | 2022-2025 | Nucala, Trelegy Ellipta |
| Covidien LP | $197.76 | 2019 | |
| Olympus America INC. | $189.11 | 2023-2024 | Spiration Valve System, Always-On Tip Tracked Forceps, 1.8mm Od, Serrated Cup |
| Insmed, INC. | $176.54 | 2019-2025 | Arikayce |
| Genentech USA, INC. | $169.67 | 2019-2021 | |
| Tactile Systems Technology INC | $162.70 | 2025 | Flexitouch Plus, Nimbl |
| Boston Scientific Corporation | $156.18 | 2019-2025 | General - Pulmonary |
| Ethicon INC. | $147.65 | 2019-2022 | |
| Actelion Pharmaceuticals US, INC. | $147.12 | 2023 | Uptravi, Opsumit |
| Ambu INC. | $120.42 | 2023 | |
| Caris Mpi, INC. | $106.41 | 2025 | Mi Cancer Seek |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Advanced Respiratory, INC | $43.11 | 2021 | |
| Genzyme Corporation | $41.64 | 2022-2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Crawley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.